MAG
HALO icon

MRA Advisory Group’s Halozyme HALO Stock Holding History

MRA Advisory Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,843
Closed -$507K – 166
2026
Q1 		$507K Buy
7,843
+448
+6% +$31.6K 0.21% 69
2025
Q4 		$498K Sell
7,395
-1,228
-14% -$82.6K 0.21% 65
2025
Q3 		$632K Sell
8,623
-98
-1% -$6.51K 0.28% 56
2025
Q2 		$454K Buy
+8,721
New +$496K 0.21% 73

Other funds holding HALO

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

MRA Advisory Group's HALO Position: Q2 2026 in Review

MRA Advisory Group sold out of Halozyme (HALO) in Q2 2026, closing a stake of 7,843 shares — an estimated $507K sold.

MRA Advisory Group first reported a position in HALO in Q2 2025 and held it in 4 quarters. The position peaked at $632K in Q3 2025. 156 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • MRA Advisory Group reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • MRA Advisory Group sold 7,843 Halozyme shares in Q2 2026, an estimated $507K.
  • MRA Advisory Group first reported a position in Halozyme in Q2 2025 and held it in 4 quarters.
  • MRA Advisory Group's Halozyme position peaked at $632K in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.